Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young Adults: A Randomized, Open-Label, Two-Period Crossover, Single-Centre Study

Author： Darwish Mona   Hellriegel Edward T.   Xie Fang  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.28, Iss.12, 2008-01, pp. : 793-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the Elderly: A Randomized, Open-Label, Crossover Study

By Darwish Mona  

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 95-101

Adis International

Access to resources Recommend Favorite

Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg: A Randomized, Open-Label, Crossover, Single-Centre Study

By Darwish Mona  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 145-152

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a New Once-Daily Controlled-Release Formulation of Aceclofenac in Korean Healthy Subjects Compared with Immediate-Release Aceclofenac and the Effect of Food: A Randomized, Open-Label, Three-Period, Crossover, Single-Centre Study

By >  

Clinical Drug Investigation, Vol. 32, Iss. 2, 2012-02 ,pp. : 111-119

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study

By Kandhwal Kirti  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 853-863

Adis International

Access to resources Recommend Favorite

Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate: A Randomized, Open-Label, Two-Period, Crossover, Single-Dose, Single-Centre Pharmacokinetic Study in Healthy Adult Men

By Ermer James C.  

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 357-370

Adis International

Access to resources Recommend Favorite